• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非小细胞肺癌袖状肺叶切除术的安全性及长期预后]

[Safety and long-term outcome of sleeve lobectomy for non-small cell lung cancer].

作者信息

Xie Ming-Ran, Zhang Xu, Lin Peng, Chen Jie-Xin, Ling Yong-Bin, Fu Jian-Hua, Rong Tie-Hua, Zeng Can-Guang, Huang Zhi-Fan

机构信息

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.

出版信息

Ai Zheng. 2009 Aug;28(8):868-71. doi: 10.5732/cjc.009.10028.

DOI:10.5732/cjc.009.10028
PMID:19664335
Abstract

BACKGROUND AND OBJECTIVE

Pneumonectomy has been long term used as the standard surgical procedure for central type non-small cell lung cancer (NSCLC). Sleeve lobectomy has been performed in a small number of patients meeting the indications. This study was to compare the 5-year survival rate, operation related complications and mortality of sleeve lobectomy with pneumonectomy for NSCLC, and evaluate sleeve lobectomy in the surgical treatment for NSCLC.

METHODS

Ninety-three patients with NSCLC undergoing sleeve lobectomy (group A) and 571 patients with NSCLC undergoing pneumonectomy (group B) from January 1997 to December 2007 in Sun Yat-sen University Cancer Center were reviewed. The 5-year survival rate, operation related complications and mortality between the two groups were analyzed.

RESULTS

The overall 5-year survival for group A and group B were 42.0% and 31.5%, respectively (P=0.015). In the subgroup analysis, the 5-year survival of N0 (P=0.007) and N1 (P=0.025) patients were significant higher in group A than in group B, while the survival were not significantly different between N2 patients (P=0.073). The 5-year survival rates for bronchial and pulmonary arterial sleeve resection (the subset of group A) and pneumonectomy were not significantly different (P=0.092). There was no significant difference in local recurrences between the groups (P=0.821). The postoperative complication rates were 11.8% in group A and 20.7% in group B (P=0.046). There was no statistically significant difference in mortality between the two groups (P=0.259).

CONCLUSION

The operative safety and long term efficacy of sleeve lobectomy are superior to pneumonectomy for NSCLC.

摘要

背景与目的

肺切除术长期以来一直是中央型非小细胞肺癌(NSCLC)的标准外科手术。少数符合适应证的患者接受了袖状肺叶切除术。本研究旨在比较NSCLC患者行袖状肺叶切除术与肺切除术的5年生存率、手术相关并发症及死亡率,并评估袖状肺叶切除术在NSCLC外科治疗中的价值。

方法

回顾性分析1997年1月至2007年12月在中山大学肿瘤防治中心接受袖状肺叶切除术的93例NSCLC患者(A组)和接受肺切除术的571例NSCLC患者(B组)。分析两组患者的5年生存率、手术相关并发症及死亡率。

结果

A组和B组的总体5年生存率分别为42.0%和31.5%(P = 0.015)。亚组分析显示,A组N0(P = 0.007)和N1(P = 0.025)患者的5年生存率显著高于B组,而N2患者的生存率在两组间无显著差异(P = 0.073)。支气管和肺动脉袖状切除术(A组的一个亚组)与肺切除术的5年生存率无显著差异(P = 0.092)。两组间局部复发率无显著差异(P = 0.821)。A组术后并发症发生率为11.8%,B组为20.7%(P = 0.046)。两组间死亡率无统计学显著差异(P = 0.259)。

结论

对于NSCLC患者,袖状肺叶切除术的手术安全性和长期疗效优于肺切除术。

相似文献

1
[Safety and long-term outcome of sleeve lobectomy for non-small cell lung cancer].[非小细胞肺癌袖状肺叶切除术的安全性及长期预后]
Ai Zheng. 2009 Aug;28(8):868-71. doi: 10.5732/cjc.009.10028.
2
Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.非小细胞肺癌袖状肺叶切除术后的发病率、死亡率和长期生存率
Eur J Cardiothorac Surg. 2007 Jan;31(1):95-102. doi: 10.1016/j.ejcts.2006.10.031. Epub 2006 Nov 28.
3
Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.与全肺切除术相比,袖状肺叶切除术后非小细胞肺癌淋巴结受累相关疾病的局部控制情况。
Ann Thorac Surg. 2005 Apr;79(4):1153-61; discussion 1153-61. doi: 10.1016/j.athoracsur.2004.09.011.
4
Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.袖状肺叶切除术治疗伴有 N1 淋巴结转移的非小细胞肺癌并不影响生存。
Ann Thorac Surg. 2014 Jan;97(1):230-5. doi: 10.1016/j.athoracsur.2013.09.016. Epub 2013 Nov 6.
5
Survival after bronchoplastic lobectomy for non small cell lung cancer compared with pneumonectomy according to nodal status.根据淋巴结状态,非小细胞肺癌支气管成形肺叶切除术后与全肺切除术后的生存率比较
J Cardiovasc Surg (Torino). 2002 Feb;43(1):103-8.
6
Sleeve lobectomy for bronchogenic cancers: factors affecting survival.支气管源性癌的袖状肺叶切除术:影响生存的因素
Ann Thorac Surg. 2002 Sep;74(3):851-8; discussion 858-9. doi: 10.1016/s0003-4975(02)03792-x.
7
Sleeve lobectomy for non-small cell lung cancer.非小细胞肺癌的袖状肺叶切除术
Acta Chir Belg. 2003 Nov-Dec;103(6):570-6. doi: 10.1080/00015458.2003.11679493.
8
[Sleeve lobectomy compared to pneumonectomy for the treatment of N0-N1 non-small cell lung cancer].[袖状肺叶切除术与全肺切除术治疗N0-N1期非小细胞肺癌的比较]
Arch Bronconeumol. 2006 Apr;42(4):160-4. doi: 10.1016/s1579-2129(06)60436-9.
9
Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases.非小细胞肺癌和类癌的袖状肺叶切除术:160例病例的结果
Eur J Cardiothorac Surg. 2002 May;21(5):888-93. doi: 10.1016/s1010-7940(02)00085-4.
10
Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.袖状肺叶切除术作为可切除肺癌患者的全肺切除术替代方案。
Neoplasma. 2013;60(1):62-7. doi: 10.4149/neo_2013_009.